Vertex Pharmaceuticals Affirms FY2026 Sales Guidance of $12.950B-$13.100B vs $13.064B Est

Benzinga Newsdesk www.benzinga.com Negative 76.2%

Neg 76.2% Neu 0% Pos 0%

Vertex Pharmaceuticals (NASDAQ:VRTX) affirms FY2026 sales outlook from $12.950 billion-$13.100 billion to $12.950 billion-$13.100 billion vs $13.064 billion estimate.